Portal de Periódicos da CAPES

Acceptability of HIV Pre-exposure Prophylaxis (PrEP) Among People Who Inject Drugs (PWID) in a Canadian Setting

2014; Springer Science+Business Media; Volume: 19; Issue: 5 Linguagem: Inglês

10.1007/s10461-014-0867-z

1573-3254

Daniel J. Escudero, Thomas Kerr, Evan Wood, Paul Nguyen, Mark N. Lurie, Omar Sued, Brandon D. L. Marshall,

Sex work and related issues

A recent clinical trial provided evidence that pre-exposure prophylaxis (PrEP) has the potential to prevent HIV infection among people who inject drugs (PWID). We examined willingness to use PrEP among HIV-negative PWID in Vancouver, Canada (n = 543) to inform PrEP implementation efforts. One third (35.4 %) expressed willingness to use PrEP, with adjusted models indicating that younger age, no regular employment, requiring help injecting, engaging in sex work, and reporting multiple recent sexual partners were positively associated with willingness to use PrEP. Although willingness to use PrEP was low, PrEP was acceptable to some PWID at heightened risk for HIV infection.